Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Occhipinti
Editorial: Real-Life Data Confirm Efficacy of Elbasvir/Grazoprevir in HCV Patients With Severe Kidney Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan
Journal of Medical Virology
Virology
Infectious Diseases
Pmu17 - Retrospective Study of Patients Using Elbasvir/Grazoprevir in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial
Hepatology
Medicine
Hepatology
An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study
Hepatology
Medicine
Hepatology
Real-Life Experiences of Patients With Parkinson's Disease
Kontakt
Environmental
Public Health
Philosophy
Nursing
Occupational Health
Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Efficacy and Safety of Hepatitis C Direct-Acting Protease Inhibitors (DAA-PI ) in Real Life in HIV-HCV Coinfected Patients
BMC Infectious Diseases
Infectious Diseases
